Evidence-Based Management of Lipid Disorders
Autor Ph.D. Vissers, Maud N., MD, Ph.D. Kastelein, John J.P., MD, Ph.D. Stroes, Erik S.en Limba Engleză Hardback – 13 iul 2010
Preț: 348.83 lei
Preț vechi: 394.80 lei
-12% Nou
Puncte Express: 523
Preț estimativ în valută:
66.77€ • 69.44$ • 55.95£
66.77€ • 69.44$ • 55.95£
Carte disponibilă
Livrare economică 20 februarie-06 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781903378717
ISBN-10: 1903378710
Pagini: 314
Ilustrații: tables & charts
Dimensiuni: 179 x 251 x 23 mm
Greutate: 1.06 kg
Ediția:New.
Editura: TFM Publishing Ltd
ISBN-10: 1903378710
Pagini: 314
Ilustrații: tables & charts
Dimensiuni: 179 x 251 x 23 mm
Greutate: 1.06 kg
Ediția:New.
Editura: TFM Publishing Ltd
Cuprins
Lipoprotein metabolism: what do we know now?; The epidemiological aspects of lipid and lipoprotein levels in relation to cardiovascular diseases; Are lifestyle modifications a successful means for controlling lipid levels in the long run?; What are the diagnostic and therapeutic strategies for hereditary hypo-and hypercholesterolaemia?; Does raising HDL protect against atherosclerosis?; How do we diagnose hypertriglyceridaemia in clinical practice and what are the consequences for treatment?; What is the optimal treatment of familial combined hypercholesterolaemia?; How should we manage lipid and lipoprotein disorders in children?; What is the role of dyslipidaemia in the metabolic syndrome and diabetes mellitus?; What are the consequences of renal insufficiency or the nephrotic syndrome for lipid levels?; Is there a link between chronic inflammatory diseases and cardiovascular risk?; What is the evidence for a physiological and pathogenic role of lipoprotein (a)?; How do we identify and treat sitosterolaemia?; How can we deal with inborn errors in cholesterol and bile acid biosynthesis?; Differential diagnosis of patients with tendon xanthomas; When should we fear for statin interactions?; What are the considerations in patients who are statin resistant?